» Articles » PMID: 8281852

Variability in Individual Response to Various Doses of Omeprazole. Implications for Antiulcer Therapy

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1994 Jan 1
PMID 8281852
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

This study was carried out in order to perform a combined prospective assessment of the individual pharmacodynamic response and of duodenal ulcer healing in patients treated with three different doses of omeprazole. Ninety-nine patients with endoscopically proven duodenal ulcers were subdivided into three parallel groups of 33 cases, who were randomly assigned to receive orally at 0800 hr, in single blind fashion, either 10 mg, 20 mg, or 40 mg of omeprazole. All of them underwent continuous intragastric pH monitoring both in basal conditions and on the fifth day of each dose regimen; ulcer healing was then assessed endoscopically after four weeks of treatment. All three doses of omeprazole caused pH values to increase significantly (P < 0.001) over the whole 24-hr period. In patients treated with omeprazole 10 mg, the individual responses showed the highest variability: the acid inhibition, expressed in terms of time spent above pH 3.0, lasted for more than 16 hr in 42% of cases, for more than 8 hr in 28%, and for less than 6 hr in 30%. In patients treated with omeprazole 20 mg, the pharmacological response was more marked and uniform and lasted for more than 16 hr in 79% of cases; however, it is worth noting it lasted for less than 6 hr in three patients (10%). In patients treated with omeprazole 40 mg, the individual response was excellent (more than 16 hr) in 94% of cases, and it lasted for less than 6 hr in only one patient (3%).(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.

Cloud M, Enas N, Humphries T, Bassion S Dig Dis Sci. 1998; 43(5):993-1000.

PMID: 9590413 DOI: 10.1023/a:1018822532736.


Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.

Labenz J, Peitz U, Leusing C, Tillenburg B, Blum A, Borsch G Gut. 1997; 40(1):36-41.

PMID: 9155573 PMC: 1027005. DOI: 10.1136/gut.40.1.36.


Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.

Holloway R, Dent J, Narielvala F, MacKinnon A Gut. 1996; 38(5):649-54.

PMID: 8707107 PMC: 1383143. DOI: 10.1136/gut.38.5.649.


Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.

Savarino V, Mela G, Zentilin P, Cutela P, Mele M, Perilli D Dig Dis Sci. 1994; 39(7):1473-82.

PMID: 8026259 DOI: 10.1007/BF02088051.


Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator Group.

Bate C, Booth S, Crowe J, Mountford R, Keeling P, Taylor M Gut. 1995; 36(4):492-8.

PMID: 7737552 PMC: 1382485. DOI: 10.1136/gut.36.4.492.

References
1.
Maton P . Omeprazole. N Engl J Med. 1991; 324(14):965-75. DOI: 10.1056/NEJM199104043241406. View

2.
Festen H . Effects of omeprazole on gastric secretory functions. Digestion. 1989; 44 Suppl 1:18-24. DOI: 10.1159/000200100. View

3.
Graham D, McCullough A, Sklar M, Sontag S, ROUFAIL W, Stone R . Omeprazole versus placebo in duodenal ulcer healing. The United States experience. Dig Dis Sci. 1990; 35(1):66-72. DOI: 10.1007/BF01537225. View

4.
Mela G, Savarino V, Moretti M, Bonifacino G, Sumberaz A, Zentilin P . Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases. Scand J Gastroenterol. 1989; 24(6):683-7. DOI: 10.3109/00365528909093109. View

5.
Savarino V, Mela G, Zentilin P, Scalabrini P, Bonifacino G, Gambaro P . Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording. Digestion. 1989; 42(1):1-6. DOI: 10.1159/000199818. View